Baudax Bio Stock Surges 90%

Shares of Baudax Bio, Inc. (BXRX) are surging nearly 90% on Thursday morning, despite no stock-related statement from the company.

BXRX is currently trading at $4.3699, up $2.0699 or 89.9957%, on the Nasdaq, on a huge volume of 13.0 million shares, above average volume of 1.3 million. The stock opened its trading at $2.1100 after closing previous day at $2.3000. The stock has traded between $0.1210 and $10.0800 in the past 52-week period.

Baudax Bio, a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Follow RTT